- Home
- OBT vs TSHA Comparison
OBT vs TSHA Comparison
Compare OBT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- TSHA
- Stock Information
- Founded
- OBT 1892
- TSHA 2019
- Country
- OBT United States
- TSHA United States
- Employees
- OBT N/A
- TSHA N/A
- Industry
- OBT Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- TSHA Health Care
- Exchange
- OBT Nasdaq
- TSHA Nasdaq
- Market Cap
- OBT 267.9M
- TSHA 397.8M
- IPO Year
- OBT N/A
- TSHA 2020
- Fundamental
- Price
- OBT $25.80
- TSHA $2.13
- Analyst Decision
- OBT Buy
- TSHA Strong Buy
- Analyst Count
- OBT 1
- TSHA 8
- Target Price
- OBT $35.50
- TSHA $6.63
- AVG Volume (30 Days)
- OBT 22.7K
- TSHA 3.0M
- Earning Date
- OBT 04-30-2025
- TSHA 05-16-2025
- Dividend Yield
- OBT 1.91%
- TSHA N/A
- EPS Growth
- OBT N/A
- TSHA N/A
- EPS
- OBT 2.41
- TSHA N/A
- Revenue
- OBT $100,883,000.00
- TSHA $8,333,000.00
- Revenue This Year
- OBT $12.69
- TSHA N/A
- Revenue Next Year
- OBT $6.00
- TSHA N/A
- P/E Ratio
- OBT $10.54
- TSHA N/A
- Revenue Growth
- OBT N/A
- TSHA N/A
- 52 Week Low
- OBT $20.97
- TSHA $1.05
- 52 Week High
- OBT $33.06
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- OBT 60.03
- TSHA 58.69
- Support Level
- OBT $24.18
- TSHA $1.85
- Resistance Level
- OBT $26.67
- TSHA $2.28
- Average True Range (ATR)
- OBT 1.26
- TSHA 0.26
- MACD
- OBT 0.33
- TSHA 0.03
- Stochastic Oscillator
- OBT 76.01
- TSHA 52.96
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.